Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
HER2阳性转移性乳腺癌患者长期使用曲妥珠单抗期间的心脏毒性:哪些患者需要进行心脏监测?
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-020-06039-w
Bouwer, N I; Steenbruggen, T G; van Rosmalen, J; Rier, H N; Kitzen, J J E M; van Bekkum, M L; Tije, A J Ten; de Jong, P C; Drooger, J C; Holterhues, C; Smorenburg, C H; Kofflard, M J M; Boersma, E; Sonke, G S; Levin, M-D; Jager, A